speb/financial-data huggingface dataset:
AMSF balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 41000.00
AMSF income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 40660000.00
AMSF income_statement (quarterly, 2025-06-30) — Pretax Income: 17455000.00
AMSF cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -9675000.00
AMSF cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1082000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Receivables: 291968000.00
AMSF income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 195000.00
AMSF cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -2796000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 92097000.00
AMSF income_statement (quarterly, 2025-06-30) — Salaries And Wages: 7459000.00
AMSF cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 33888000.00
AMSF income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7459000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Share Issued: 20764355.00
AMSF cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 743000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 265570000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 265570000.00
AMSF income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2025-06-30) — Tax Provision: 3500000.00
AMSF income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 2395000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Total Assets: 1155114000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 265570000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 265570000.00
AMSF income_statement (quarterly, 2025-06-30) — Total Expenses: 63645000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 889544000.00
AMSF balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1745608.00
AMSF balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 44848000.00
AMSF cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -1829000.00
AMSF income_statement (quarterly, 2025-09-30) — +Total Revenue: 81984000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 281800000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 7632000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 225951000.00
AMSF income_statement (quarterly, 2025-09-30) — Basic Average Shares: 18980807.00
AMSF income_statement (quarterly, 2025-09-30) — Basic EPS: 0.73
AMSF cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 48465000.00
AMSF cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -891000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Capital Stock: 208000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 54747000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 144237000.00
AMSF cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -7503000.00
AMSF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -9008000.00
AMSF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 4608000.00
AMSF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 10682000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 279000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 317000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 1720000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1868000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Payable: 279000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 279000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2361000.00
AMSF cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -230000.00
AMSF cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1715000.00
AMSF cash_flow (quarterly, 2025-09-30) — Changes In Cash: 6282000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Common Stock: 208000.00
AMSF cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -7503000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 274773000.00
AMSF cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1347000.00
AMSF cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 186000.00
AMSF cash_flow (quarterly, 2025-09-30) — Deferred Tax: 186000.00
AMSF cash_flow (quarterly, 2025-09-30) — Depreciation: 183000.00
AMSF cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 183000.00
AMSF income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 19072061.00
AMSF income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.72
AMSF income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 13818000.00
AMSF cash_flow (quarterly, 2025-09-30) — End Cash Position: 54747000.00
AMSF cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -9008000.00
AMSF cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 9791000.00
AMSF cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -8000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3677000.00
AMSF income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 8327000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Invested Capital: 274773000.00
AMSF cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 4608000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 762280000.00
AMSF cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -21000.00
AMSF income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 41679000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1347000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income: 13818000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 13818000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 13818000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 13818000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 13818000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 13818000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 13818000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 5499000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -21000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Net PPE: 7270000.00
AMSF cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -891000.00
AMSF income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 41679000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 274773000.00
AMSF income_statement (quarterly, 2025-09-30) — Normalized Income: 13818000.00
AMSF cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 10682000.00
AMSF cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -8000.00
AMSF income_statement (quarterly, 2025-09-30) — Operating Revenue: 81984000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 18992255.00
AMSF balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3677000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 89490000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 0.00
AMSF income_statement (quarterly, 2025-09-30) — Policyholder Benefits Gross: 41679000.00
AMSF income_statement (quarterly, 2025-09-30) — Pretax Income: 17481000.00
AMSF cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -19878000.00
AMSF cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -891000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Receivables: 292299000.00
AMSF income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 183000.00
AMSF cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -21000.00
AMSF cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1347000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 98486000.00
AMSF income_statement (quarterly, 2025-09-30) — Salaries And Wages: 8327000.00
AMSF cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 25377000.00
AMSF income_statement (quarterly, 2025-09-30) — Selling General And Administration: 8327000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Share Issued: 20768723.00
AMSF cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 805000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 274773000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 274773000.00
AMSF income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2025-09-30) — Tax Provision: 3663000.00
AMSF income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
AMSF balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 2867000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Total Assets: 1164944000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 274773000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 274773000.00
AMSF income_statement (quarterly, 2025-09-30) — Total Expenses: 64503000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 890171000.00
AMSF balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1776468.00
AMSF balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 46195000.00
AMSF cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -4117000.00
AMSF income_statement (annual, 2025-12-31) — +Total Revenue: 317295000.00
AMSF income_statement (quarterly, 2025-12-31) — +Total Revenue: 81598000.00
AMSF balance_sheet (annual, 2025-12-31) — Accounts Receivable: 269042000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 269042000.00
AMSF balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 6963000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 6963000.00
AMSF balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 225912000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 225912000.00
AMSF income_statement (annual, 2025-12-31) — Basic Average Shares: 18979465.00
AMSF income_statement (quarterly, 2025-12-31) — Basic Average Shares: 18864228.00
AMSF income_statement (annual, 2025-12-31) — Basic EPS: 2.48
AMSF income_statement (quarterly, 2025-12-31) — Basic EPS: 0.55
AMSF cash_flow (annual, 2025-12-31) — Beginning Cash Position: 44045000.00
AMSF cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 54747000.00
AMSF cash_flow (annual, 2025-12-31) — Capital Expenditure: -2148000.00
AMSF cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -173000.00
AMSF balance_sheet (annual, 2025-12-31) — Capital Stock: 208000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Capital Stock: 208000.00
AMSF balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 61926000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 61926000.00
AMSF balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 149363000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 149363000.00
AMSF cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -48607000.00
AMSF cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -26194000.00
AMSF cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -61612000.00
AMSF cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -34183000.00
AMSF cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 68423000.00
AMSF cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 30739000.00
AMSF cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11070000.00
AMSF cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10623000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Account Payable: 1863000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2099000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -135000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -1101000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 147000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1006000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 9127000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 6011000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Payable: 1863000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Payable: -2099000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1863000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2099000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Receivables: -18782000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Receivables: 7239000.00
AMSF cash_flow (annual, 2025-12-31) — Change In Working Capital: -33863000.00
AMSF cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -620000.00
AMSF cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -18238000.00
AMSF cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 6791000.00
AMSF cash_flow (annual, 2025-12-31) — Changes In Cash: 17881000.00
AMSF cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7179000.00
AMSF balance_sheet (annual, 2025-12-31) — Common Stock: 208000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Common Stock: 208000.00
AMSF cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -48607000.00
AMSF cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -26194000.00
AMSF balance_sheet (annual, 2025-12-31) — Common Stock Equity: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 251598000.00
AMSF cash_flow (annual, 2025-12-31) — Common Stock Payments: -12103000.00
AMSF cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -7960000.00
AMSF cash_flow (annual, 2025-12-31) — Deferred Income Tax: 372000.00
AMSF cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 1160000.00
AMSF cash_flow (annual, 2025-12-31) — Deferred Tax: 372000.00
AMSF cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1160000.00
AMSF cash_flow (annual, 2025-12-31) — Depreciation: 742000.00
AMSF cash_flow (quarterly, 2025-12-31) — Depreciation: 150000.00
AMSF cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 742000.00
AMSF cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 150000.00
AMSF income_statement (annual, 2025-12-31) — Diluted Average Shares: 19082142.00
AMSF income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 18967428.00
AMSF income_statement (annual, 2025-12-31) — Diluted EPS: 2.47
AMSF income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.55
AMSF income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 10423000.00
AMSF cash_flow (annual, 2025-12-31) — End Cash Position: 61926000.00
AMSF cash_flow (quarterly, 2025-12-31) — End Cash Position: 61926000.00
AMSF cash_flow (annual, 2025-12-31) — Financing Cash Flow: -61612000.00
AMSF cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -34183000.00
AMSF cash_flow (annual, 2025-12-31) — Free Cash Flow: 8922000.00
AMSF cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 10450000.00
AMSF cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -3077000.00
AMSF cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 77000.00
AMSF balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3217000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3217000.00
AMSF income_statement (annual, 2025-12-31) — General And Administrative Expense: 33264000.00
AMSF income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 9194000.00
AMSF cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 12450000.00
AMSF balance_sheet (annual, 2025-12-31) — Invested Capital: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Invested Capital: 251598000.00
AMSF cash_flow (annual, 2025-12-31) — Investing Cash Flow: 68423000.00
AMSF cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 30739000.00
AMSF balance_sheet (annual, 2025-12-31) — Investments And Advances: 734855000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 734855000.00
AMSF cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -85000.00
AMSF cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -22000.00
AMSF income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 169937000.00
AMSF income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 47439000.00
AMSF cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -12103000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -7960000.00
AMSF income_statement (annual, 2025-12-31) — Net Income: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income: 10423000.00
AMSF income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 10423000.00
AMSF income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 10423000.00
AMSF income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10423000.00
AMSF income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10423000.00
AMSF cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 47145000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 10423000.00
AMSF income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 10423000.00
AMSF cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 70571000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 30912000.00
AMSF cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -85000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -22000.00
AMSF cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -85000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -22000.00
AMSF balance_sheet (annual, 2025-12-31) — Net PPE: 7293000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Net PPE: 7293000.00
AMSF cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2148000.00
AMSF cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -173000.00
AMSF income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 169937000.00
AMSF income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 47439000.00
AMSF balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 251598000.00
AMSF income_statement (annual, 2025-12-31) — Normalized Income: 47145000.00
AMSF income_statement (quarterly, 2025-12-31) — Normalized Income: 10423000.00
AMSF cash_flow (annual, 2025-12-31) — Operating Cash Flow: 11070000.00
AMSF cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 10623000.00
AMSF cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3077000.00
AMSF cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 77000.00
AMSF income_statement (annual, 2025-12-31) — Operating Revenue: 317295000.00
AMSF income_statement (quarterly, 2025-12-31) — Operating Revenue: 81598000.00
AMSF balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 18794881.00
AMSF balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 18794881.00
AMSF balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -3217000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -3217000.00
AMSF cash_flow (annual, 2025-12-31) — Other Non Cash Items: 563000.00
AMSF cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 72000.00
AMSF balance_sheet (annual, 2025-12-31) — Other Payable: 2032000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Other Payable: 2032000.00
AMSF balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 87437000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 87437000.00
AMSF balance_sheet (annual, 2025-12-31) — Payables: 2032000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Payables: 2032000.00
AMSF balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2032000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2032000.00
AMSF income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 169937000.00
AMSF income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 47439000.00
AMSF income_statement (annual, 2025-12-31) — Pretax Income: 58851000.00
AMSF income_statement (quarterly, 2025-12-31) — Pretax Income: 12694000.00
AMSF cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -817000.00
AMSF cash_flow (annual, 2025-12-31) — Purchase Of Investment: -67000000.00
AMSF cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -26949000.00
AMSF cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2148000.00
AMSF cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -173000.00
AMSF balance_sheet (annual, 2025-12-31) — Receivables: 279093000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Receivables: 279093000.00
AMSF income_statement (annual, 2025-12-31) — Reconciled Depreciation: 742000.00
AMSF income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 150000.00
AMSF cash_flow (annual, 2025-12-31) — Repayment Of Debt: -85000.00
AMSF cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -22000.00
AMSF cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -12103000.00
AMSF cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -7960000.00
AMSF balance_sheet (annual, 2025-12-31) — Retained Earnings: 82850000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 82850000.00
AMSF income_statement (annual, 2025-12-31) — Salaries And Wages: 33264000.00
AMSF income_statement (quarterly, 2025-12-31) — Salaries And Wages: 9194000.00
AMSF cash_flow (annual, 2025-12-31) — Sale Of Investment: 137571000.00
AMSF cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 57861000.00
AMSF income_statement (annual, 2025-12-31) — Selling General And Administration: 33264000.00
AMSF income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9194000.00
AMSF balance_sheet (annual, 2025-12-31) — Share Issued: 20769021.00
AMSF balance_sheet (quarterly, 2025-12-31) — Share Issued: 20769021.00
AMSF cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2907000.00
AMSF cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 286000.00
AMSF balance_sheet (annual, 2025-12-31) — Stockholders Equity: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 251598000.00
AMSF balance_sheet (annual, 2025-12-31) — Tangible Book Value: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 251598000.00
AMSF income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (annual, 2025-12-31) — Tax Provision: 11706000.00
AMSF income_statement (quarterly, 2025-12-31) — Tax Provision: 2271000.00
AMSF income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
AMSF income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
AMSF balance_sheet (annual, 2025-12-31) — Taxes Receivable: 3088000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 3088000.00
AMSF balance_sheet (annual, 2025-12-31) — Total Assets: 1130544000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Total Assets: 1130544000.00
AMSF balance_sheet (annual, 2025-12-31) — Total Capitalization: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 251598000.00
AMSF balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 251598000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 251598000.00
AMSF income_statement (annual, 2025-12-31) — Total Expenses: 258444000.00
AMSF income_statement (quarterly, 2025-12-31) — Total Expenses: 68904000.00
AMSF balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 878946000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 878946000.00
AMSF balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1974140.00
AMSF balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1974140.00
AMSF balance_sheet (annual, 2025-12-31) — Treasury Stock: 54155000.00
AMSF balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 54155000.00
AMSF cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -3719000.00
AMSF cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -925000.00
AMSF income_statement (quarterly, 2026-03-31) — +Total Revenue: 80098000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 280012000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 7196000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 226944000.00
AMSF cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 9000.00
AMSF income_statement (quarterly, 2026-03-31) — Basic Average Shares: 18759526.00
AMSF income_statement (quarterly, 2026-03-31) — Basic EPS: 0.43
AMSF cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 61926000.00
AMSF cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -26000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Capital Stock: 208000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 34226000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 123789000.00
AMSF cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -7766000.00
AMSF cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -12527000.00
AMSF cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -12475000.00
AMSF cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2698000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 676000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2667000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 1593000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 3088000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Payable: 676000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 676000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Receivables: -12448000.00
AMSF cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -13162000.00
AMSF cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -14106000.00
AMSF cash_flow (quarterly, 2026-03-31) — Changes In Cash: -27700000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Common Stock: 208000.00
AMSF cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -7766000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 246597000.00
AMSF cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -4031000.00
AMSF cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -99000.00
AMSF cash_flow (quarterly, 2026-03-31) — Deferred Tax: -99000.00
AMSF cash_flow (quarterly, 2026-03-31) — Depreciation: 175000.00
AMSF cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 175000.00
AMSF income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 18863395.00
AMSF income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.43
AMSF income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8145000.00
AMSF cash_flow (quarterly, 2026-03-31) — End Cash Position: 34226000.00
AMSF cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -12527000.00
AMSF cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2724000.00
AMSF cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -5000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -5665000.00
AMSF income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7986000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Invested Capital: 246597000.00
AMSF cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -12475000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 739350000.00
AMSF cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -21000.00
AMSF income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 46440000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -4031000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income: 8145000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8145000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8145000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8145000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8145000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 8145000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8145000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -12449000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -21000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -21000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -709000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Net PPE: 7144000.00
AMSF cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -26000.00
AMSF income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 46440000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 246597000.00
AMSF income_statement (quarterly, 2026-03-31) — Normalized Income: 8145000.00
AMSF cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2698000.00
AMSF cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -5000.00
AMSF income_statement (quarterly, 2026-03-31) — Operating Revenue: 80098000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18703771.00
AMSF balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -5665000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Other Payable: 835000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 89563000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Payables: 835000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 835000.00
AMSF income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 46440000.00
AMSF income_statement (quarterly, 2026-03-31) — Pretax Income: 10160000.00
AMSF cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -35317000.00
AMSF cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -26000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Receivables: 288405000.00
AMSF income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 175000.00
AMSF cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -21000.00
AMSF cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -4031000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 83296000.00
AMSF income_statement (quarterly, 2026-03-31) — Salaries And Wages: 7986000.00
AMSF cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 22868000.00
AMSF income_statement (quarterly, 2026-03-31) — Selling General And Administration: 7986000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Share Issued: 20797870.00
AMSF cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 586000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 246597000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 246597000.00
AMSF income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2026-03-31) — Tax Provision: 2015000.00
AMSF income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1197000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Total Assets: 1122959000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 246597000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 246597000.00
AMSF income_statement (quarterly, 2026-03-31) — Total Expenses: 69938000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 876362000.00
AMSF balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2094099.00
AMSF balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 58186000.00
AMSF cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 1653000.00
AMSF income_statement (quarterly, 2026-06-30) — +Total Revenue: 91976000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 288794000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Accrued Interest Receivable: 6930000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 227323000.00
AMSF cash_flow (quarterly, 2026-06-30) — Amortization Of Securities: -23000.00
AMSF income_statement (quarterly, 2026-06-30) — Basic Average Shares: 18579890.00
AMSF income_statement (quarterly, 2026-06-30) — Basic EPS: 0.79
AMSF cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 34226000.00
AMSF cash_flow (quarterly, 2026-06-30) — Capital Expenditure: -3000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Capital Stock: 208000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 65476000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 125387000.00
AMSF cash_flow (quarterly, 2026-06-30) — Cash Dividends Paid: -7626000.00
AMSF cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Financing Activities: -13269000.00
AMSF cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Investing Activities: 42726000.00
AMSF cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Operating Activities: 1793000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Account Payable: 3191000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Other Current Assets: 1096000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Other Current Liabilities: 1838000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Other Working Capital: -747000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Payable: 3191000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Payables And Accrued Expense: 3191000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Receivables: -7914000.00
AMSF cash_flow (quarterly, 2026-06-30) — Change In Working Capital: -6320000.00
AMSF cash_flow (quarterly, 2026-06-30) — Changes In Account Receivables: -8357000.00
AMSF cash_flow (quarterly, 2026-06-30) — Changes In Cash: 31250000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Common Stock: 208000.00
AMSF cash_flow (quarterly, 2026-06-30) — Common Stock Dividend Paid: -7626000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Common Stock Equity: 249991000.00
AMSF cash_flow (quarterly, 2026-06-30) — Common Stock Payments: -5624000.00
AMSF cash_flow (quarterly, 2026-06-30) — Deferred Income Tax: 610000.00
AMSF cash_flow (quarterly, 2026-06-30) — Deferred Tax: 610000.00
AMSF cash_flow (quarterly, 2026-06-30) — Depreciation: 178000.00
AMSF cash_flow (quarterly, 2026-06-30) — Depreciation And Amortization: 178000.00
AMSF income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 18702282.00
AMSF income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.78
AMSF income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 14595000.00
AMSF cash_flow (quarterly, 2026-06-30) — End Cash Position: 65476000.00
AMSF cash_flow (quarterly, 2026-06-30) — Financing Cash Flow: -13269000.00
AMSF cash_flow (quarterly, 2026-06-30) — Free Cash Flow: 1790000.00
AMSF cash_flow (quarterly, 2026-06-30) — Gain Loss On Investment Securities: 82000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Gains Losses Not Affecting Retained Earnings: -3980000.00
AMSF income_statement (quarterly, 2026-06-30) — General And Administrative Expense: 8499000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Invested Capital: 249991000.00
AMSF cash_flow (quarterly, 2026-06-30) — Investing Cash Flow: 42726000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Investments And Advances: 705187000.00
AMSF cash_flow (quarterly, 2026-06-30) — Long Term Debt Payments: -19000.00
AMSF income_statement (quarterly, 2026-06-30) — Loss Adjustment Expense: 48341000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net Common Stock Issuance: -5624000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income: 14595000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 14595000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 14595000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 14595000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 14595000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net Income From Continuing Operations: 14595000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 14595000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net Investment Purchase And Sale: 42729000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net Issuance Payments Of Debt: -19000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net Long Term Debt Issuance: -19000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Net PPE: 6951000.00
AMSF cash_flow (quarterly, 2026-06-30) — Net PPE Purchase And Sale: -3000.00
AMSF income_statement (quarterly, 2026-06-30) — Net Policyholder Benefits And Claims: 48341000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Net Tangible Assets: 249991000.00
AMSF income_statement (quarterly, 2026-06-30) — Normalized Income: 14595000.00
AMSF cash_flow (quarterly, 2026-06-30) — Operating Cash Flow: 1793000.00
AMSF cash_flow (quarterly, 2026-06-30) — Operating Gains Losses: 101000.00
AMSF income_statement (quarterly, 2026-06-30) — Operating Revenue: 91976000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Ordinary Shares Number: 18703771.00
AMSF balance_sheet (quarterly, 2026-06-30) — Other Equity Adjustments: -3980000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Other Short Term Investments: 59911000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Payables And Accrued Expenses: 0.00
AMSF income_statement (quarterly, 2026-06-30) — Policyholder Benefits Gross: 48341000.00
AMSF income_statement (quarterly, 2026-06-30) — Pretax Income: 18265000.00
AMSF cash_flow (quarterly, 2026-06-30) — Purchase Of Investment: -7414000.00
AMSF cash_flow (quarterly, 2026-06-30) — Purchase Of PPE: -3000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Receivables: 296744000.00
AMSF income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 178000.00
AMSF cash_flow (quarterly, 2026-06-30) — Repayment Of Debt: -19000.00
AMSF cash_flow (quarterly, 2026-06-30) — Repurchase Of Capital Stock: -5624000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Retained Earnings: 90250000.00
AMSF income_statement (quarterly, 2026-06-30) — Salaries And Wages: 8499000.00
AMSF cash_flow (quarterly, 2026-06-30) — Sale Of Investment: 50143000.00
AMSF income_statement (quarterly, 2026-06-30) — Selling General And Administration: 8499000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Share Issued: 18703771.00
AMSF cash_flow (quarterly, 2026-06-30) — Stock Based Compensation: 765000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: 249991000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: 249991000.00
AMSF income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
AMSF income_statement (quarterly, 2026-06-30) — Tax Provision: 3670000.00
AMSF income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.20
AMSF balance_sheet (quarterly, 2026-06-30) — Taxes Receivable: 1020000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Total Assets: 1127291000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 249991000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: 249991000.00
AMSF income_statement (quarterly, 2026-06-30) — Total Expenses: 73711000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 877300000.00
AMSF balance_sheet (quarterly, 2026-06-30) — Treasury Stock: 63810000.00
AMSF cash_flow (quarterly, 2026-06-30) — Unrealized Gain Loss On Investment Securities: -8113000.00
AMSS income_statement (annual, 2024-12-31) — +Operating Expense: 14329980.00
AMSS income_statement (annual, 2024-12-31) — +Total Revenue: 21668525.00
AMSS balance_sheet (annual, 2024-12-31) — Accounts Payable: 8412794.00
AMSS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3341357.00
AMSS balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 0.00
AMSS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -494501.00
AMSS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 35881552.00
AMSS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 541716.00
AMSS cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 541716.00
AMSS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1383962.00
AMSS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 5672020.00
AMSS income_statement (annual, 2024-12-31) — Basic Average Shares: 10848077.00
AMSS income_statement (annual, 2024-12-31) — Basic EPS: -1.41
AMSS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 939975.00
AMSS cash_flow (annual, 2024-12-31) — Capital Expenditure: -12900.00
AMSS balance_sheet (annual, 2024-12-31) — Capital Stock: 245.00
AMSS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 693946.00
AMSS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 693946.00
AMSS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 450631.00
AMSS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 5112656.00
AMSS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -5806377.00
AMSS cash_flow (annual, 2024-12-31) — Change In Account Payable: 762225.00
AMSS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 3102350.00
AMSS cash_flow (annual, 2024-12-31) — Change In Interest Payable: -230382.00
AMSS cash_flow (annual, 2024-12-31) — Change In Inventory: -3389003.00
AMSS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 4915.00
AMSS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 2919690.00
AMSS cash_flow (annual, 2024-12-31) — Change In Payable: 762225.00
AMSS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3864575.00
AMSS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1271882.00
AMSS cash_flow (annual, 2024-12-31) — Change In Receivables: 1024685.00
AMSS cash_flow (annual, 2024-12-31) — Change In Working Capital: 5696744.00
AMSS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 861996.00
AMSS cash_flow (annual, 2024-12-31) — Changes In Cash: -243090.00
AMSS balance_sheet (annual, 2024-12-31) — Common Stock: 29.00
AMSS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 9811727.00
AMSS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
AMSS income_statement (annual, 2024-12-31) — Cost Of Revenue: 19581499.00
AMSS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 4868809.00
AMSS balance_sheet (annual, 2024-12-31) — Current Assets: 21602179.00
AMSS balance_sheet (annual, 2024-12-31) — Current Debt: 6411303.00
AMSS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6411303.00
AMSS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 2919691.00
AMSS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 2919691.00
AMSS balance_sheet (annual, 2024-12-31) — Current Liabilities: 22612597.00
AMSS cash_flow (annual, 2024-12-31) — Depreciation: 121776.00
AMSS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 663492.00
AMSS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 663492.00
AMSS balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
AMSS income_statement (annual, 2024-12-31) — Diluted Average Shares: 10848077.00
AMSS income_statement (annual, 2024-12-31) — Diluted EPS: -1.41
AMSS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -15242690.00
AMSS balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 1268341.00
AMSS income_statement (annual, 2024-12-31) — EBIT: -13449543.00
AMSS income_statement (annual, 2024-12-31) — EBITDA: -12786051.00
AMSS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2939.00
AMSS cash_flow (annual, 2024-12-31) — End Cash Position: 693946.00
AMSS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 450631.00
AMSS balance_sheet (annual, 2024-12-31) — Finished Goods: 9085465.00
AMSS cash_flow (annual, 2024-12-31) — Free Cash Flow: -5819277.00
AMSS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 363982.00
AMSS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
AMSS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 212240.00
AMSS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 57459.00
AMSS income_statement (annual, 2024-12-31) — General And Administrative Expense: 10039494.00
AMSS balance_sheet (annual, 2024-12-31) — Goodwill: 8705994.00
AMSS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 11770234.00
AMSS balance_sheet (annual, 2024-12-31) — Gross PPE: 662680.00
AMSS income_statement (annual, 2024-12-31) — Gross Profit: 2087026.00
AMSS income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 322049.00
AMSS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 38706.00
AMSS income_statement (annual, 2024-12-31) — Interest Expense: 1805985.00
AMSS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1805985.00
AMSS income_statement (annual, 2024-12-31) — Interest Income: 117523.00
AMSS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 117523.00
AMSS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1858764.00
AMSS balance_sheet (annual, 2024-12-31) — Interest Payable: 633744.00
AMSS balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -1986114.00
AMSS balance_sheet (annual, 2024-12-31) — Inventory: 15318703.00